Salarius Pharmaceuticals Enrolls First Patient in a Phase 1 Clinical Study of its Novel Inhibitor Targeting Epigenetics in Patients with Advanced Solid Tumors

July 22, 2019

We're not around right now. But you can send us an email and we'll get back to you, asap.

Start typing and press Enter to search